BIOAVAILABILITY VS CONVENIENCE: A COMPARATIVE PHARMACEUTICO-CLINICAL ANALYSIS OF CHURNA (POWDER) AND VATI (TABLET) DOSAGE FORMS IN AYURVEDIC THERAPEUTICS
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
The modernization of Ayurvedic pharmaceutics has seen a massive shift from traditional powders (Churna) to compressed tablets (Vati/Gutika), driven primarily by patient compliance and convenience. However, this shift raises critical pharmacokinetic questions regarding efficacy, onset of action, and bioavailability. This paper analyzes the comparative pharmacodynamics of Churna and Vati, exploring the "Convenience Tax"—the potential loss of therapeutic potency due to compression, excipients, and the bypassing of oral sensory signaling (Rasa-Bodhana). We argue that for specific therapeutic indications, particularly Deepana (appetizer) and Pachana (digestive), the tablet form significantly compromises clinical outcomes.
Fields of Study & Subjects
Traditional Chinese Medicine Studies
Complementary and Alternative Medicine Studies
Phytochemicals and Medicinal Plants
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 1 April 2026
- Language
- EN